Henderson Jane bought APGE
January 2, 2026 · Form 4 insider transaction
Henderson Jane bought 83,690 shares of Apogee Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
83,690
Price
$0.00
Total value
N/A
InsiderHenderson Jane
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after83,690
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents the right to purchase 83,690 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.